Biaou Chabi Olaniran Alphonse, Kpozehouen Alphonse, Glèlè-Ahanhanzo Yolaine, Ayivi-Vinz Gloria, Ouro-Koura Abdou-Rahim, Azandjèmé Colette
Département d'Epidémiologie et de Biostatistiques, Institut Régional de Santé Publique, Université d'Abomey-Calavi, Bénin.
Centre de Formation en Santé Publique, Lomé, Togo.
Pan Afr Med J. 2019 Nov 20;34:155. doi: 10.11604/pamj.2019.34.155.19357. eCollection 2019.
Malaria is a major public health problem, responsible for many complications during pregnancy including inadequate intra-uterine growth and hypotrophies. The aim of this study was to determine the adherence to the 3 doses of sulfadoxine-pyrimethamine-based intermittent preventive treatment (IPT) on birthweight in the Cotonou health zone II and III.
We conducted a cross-sectional study focusing on 630 women in the postpartum period residing in the Cotonou health zone II and III and selected using a two stage sample. Data were collected through a questionnaire and a data processing form. For analysis, data were weighted and we used variance analysis to compare means and to compare proportions with Chi-square Test including estimates regarding the strength of the association by odds ratio (OR) and confidence interval at 95%.
Adherence to the 3 doses of sulfadoxine-pyrimethamine-based intermittent preventive treatment was 34.08% (CI95%: 24.84% 43.30%]. A significant birthweight-gain of 264.5 g (p < 0.001) in mothers who had received more than 3 doses of sulfadoxine-pyrimethamine-based intermittent preventive treatment and chances of having low birth weight baby was lower (OR = 0.45; p = 0.001) among these mothers compared to those who had received less than 3 doses of sulfadoxine pyrimethamine.
This study highlights low adherence to the new 3-dose regimen of sulfadoxine-pyrimethamine-based intermittent preventive treatment in the Cotonou health zone II and III, but it reflects its potential to contribute to the reduction of the risk of low birth weight. Strategies must therefore be implemented to strengthen its application for prevention of malaria and of its consequences on vulnerable targets.
疟疾是一个重大的公共卫生问题,会导致孕期出现许多并发症,包括宫内生长不足和发育迟缓。本研究的目的是确定在科托努卫生二区和三区,基于磺胺多辛-乙胺嘧啶的三剂间歇性预防治疗(IPT)对出生体重的依从性。
我们进行了一项横断面研究,聚焦于居住在科托努卫生二区和三区的630名产后妇女,采用两阶段抽样进行选择。数据通过问卷和数据处理表收集。为了进行分析,对数据进行加权,并使用方差分析来比较均值,使用卡方检验来比较比例,包括通过比值比(OR)和95%置信区间对关联强度的估计。
基于磺胺多辛-乙胺嘧啶的三剂间歇性预防治疗的依从率为34.08%(95%CI:24.84% - 43.30%)。接受超过三剂基于磺胺多辛-乙胺嘧啶的间歇性预防治疗的母亲,其出生体重显著增加264.5克(p < 0.001),与接受少于三剂磺胺多辛-乙胺嘧啶的母亲相比,这些母亲生出低体重婴儿的几率更低(OR = 0.45;p = 0.001)。
本研究凸显了在科托努卫生二区和三区,对基于磺胺多辛-乙胺嘧啶的新三剂间歇性预防治疗方案的依从性较低,但这反映出该方案在降低低出生体重风险方面的潜力。因此,必须实施相关策略来加强其应用,以预防疟疾及其对脆弱目标人群的影响。